awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q46479042-31A72BD1-9E7B-4F79-AB71-E813633058B9
Q46479042-31A72BD1-9E7B-4F79-AB71-E813633058B9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46479042-31A72BD1-9E7B-4F79-AB71-E813633058B9
Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosis.
P2860
Q46479042-31A72BD1-9E7B-4F79-AB71-E813633058B9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46479042-31A72BD1-9E7B-4F79-AB71-E813633058B9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6895eb47acb9164a6eba13e3ffe337e4a84ade99
P2860
Minimal clinically important improvement/difference (MCII/MCID) and patient acceptable symptom state (PASS): what do these concepts mean?